Vascular Biogenics Ltd. (NASDAQ: VBLT), relating to its proposed merger with Notable Labs, Inc. Under the terms of the agreement, VBLT shareholders are expected to own approximately 24% of the combined company.
Vascular Biogenics Ltd. (NASDAQ: VBLT), relating to its proposed merger with Notable Labs, Inc. Under the terms of the agreement, VBLT shareholders are expected to own approximately 24% of the combined company.